Cancer Family
Lymphocytic Neoplasm
CI-CAN-00000223Explore in graph →
HematologicNon-malignant3,037 active trials72 approved drugs345 evidence items
- NCIt
- C7065
Loading cancer entity…
Cancer Family
CI-CAN-00000223Explore in graph →
Clinical trials
12,948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07462299 | NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy | not yet recruiting | N/A | 110 | The Children's Hospital of Zhejiang University School of MedicineOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT05866757 | Discontinuation Study | recruiting | N/A | 70 | University College CorkOTHER | 1 | Mar 4, 2026 | clinicaltrials |
| NCT06789003 |
| Evaluation of a PREHABilitation Protocol Using Adapted Physical Activity (APA) for Multiple Myeloma Patients Eligible for Intensive Autologous Stem Cell Transplantation Treatment(PREHAB-APA) |
| recruiting |
| N/A |
| 120 |
| Centre Hospitalier Henri Duffaut - AvignonOTHER |
| 1 |
| Mar 3, 2026 |
| clinicaltrials |
| NCT07445438 | Feasibility of a Multi-omics Platform for Hematological Malignancies(FOCUS) | recruiting | N/A | 1,040 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Mar 3, 2026 | clinicaltrials |
| NCT06481228 | Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL | recruiting | N/A | 82 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT06481241 | Efficacy and Safety of Chemotherapy Combined With CAR-T Cells in Newly Diagnosed Adult Patients With Ph- B-ALL | recruiting | N/A | 77 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07443514 | Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma | recruiting | N/A | 3 | Institute of Oncology LjubljanaOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT07443592 | Treatment for Ph-negative ALL for Adults up to 65 Years(LAL-2025) | not yet recruiting | N/A | 330 | PETHEMA FoundationOTHER | 1 | Mar 2, 2026 | clinicaltrials |
| NCT06389305 | CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction | recruiting | N/A | 213 | Beijing GoBroad HospitalOTHER | 1 | Feb 25, 2026 | clinicaltrials |
| NCT05587972 | Real World Treatment Experience of Patients With Breast, Lung, or GI Cancer or Multiple Myeloma Using Remote Symptom Monitoring | active not recruiting | N/A | 100 | Carevive Systems, Inc.INDUSTRY | 1 | Feb 23, 2026 | clinicaltrials |
| NCT05745285 | Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care | recruiting | N/A | 400 | University of MiamiOTHER | 1 | Feb 20, 2026 | clinicaltrials |
| NCT07342179 | CAR-T Immunomonitoring in Multiple Myeloma (CART I5M)(CART I5M) | recruiting | N/A | 60 | Poitiers University HospitalOTHER | 1 | Feb 18, 2026 | clinicaltrials |
| NCT07203742 | The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment | recruiting | N/A | 60 | Ege UniversityOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07403630 | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)(IT-TCP POS) | recruiting | N/A | 300 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 1 | Feb 17, 2026 | clinicaltrials |
| NCT07406230 | Methotrexate Early Toxicity Monitoring(METoxiM) | not yet recruiting | N/A | 50 | Assistance Publique Hopitaux De MarseilleOTHER | 1 | Feb 12, 2026 | clinicaltrials |
| NCT06991920 | Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage | not yet recruiting | N/A | 50 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 0 | Feb 11, 2026 | clinicaltrials |
| NCT04368702 | CONFIRM: Magnetic Resonance Guided Radiation Therapy(CONFIRM) | recruiting | N/A | 70 | Brigham and Women's HospitalOTHER | 1 | Feb 9, 2026 | clinicaltrials |
| NCT06280924 | Prehab Prior to Stem Cell Transplantation in Multiple Myeloma(MOTIVATE) | recruiting | N/A | 30 | University of AlbertaOTHER | 1 | Feb 6, 2026 | clinicaltrials |
| NCT04575883 | HIIT in Youth With Congenital Heart Disease (MedBIKE) | recruiting | N/A | 44 | University of AlbertaOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07390071 | Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy | recruiting | N/A | 40 | University of UtahOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07388147 | Exercise Therapy for Multiple Myeloma Patients(SAPPHIRE-MM) | not yet recruiting | N/A | 71 | University Hospital HeidelbergOTHER | 1 | Feb 4, 2026 | clinicaltrials |
| NCT05839210 | Lifestyle Intervention of Food and Exercise for Lymphoma Survivors(LIFE-L) | recruiting | N/A | 140 | University of MiamiOTHER | 1 | Jan 30, 2026 | clinicaltrials |
| NCT07376720 | A Clinical Study Evaluating the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/Refractory Multiple Myeloma Who Have Received Three or More Lines of Treatment | not yet recruiting | N/A | 28 | Donghua ZhangOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07376733 | Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma | not yet recruiting | N/A | 26 | Universidad Complutense de MadridOTHER | 0 | Jan 29, 2026 | clinicaltrials |
| NCT06371768 | Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors(AYA STEPS) | recruiting | N/A | 260 | Duke UniversityOTHER | 1 | Jan 28, 2026 | clinicaltrials |
| NCT07371533 | Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)(A-319) | not yet recruiting | N/A | 18 | Shanxi Bethune HospitalOTHER | 0 | Jan 28, 2026 | clinicaltrials |
| NCT06069830 | PET and EBV DNA-directed Therapy for Localized Nasal Extranodal NK/T Cell Lymphoma(ENKTL) | recruiting | N/A | 89 | Ruijin HospitalOTHER | 1 | Jan 27, 2026 | clinicaltrials |
| NCT07366450 | High-Dose vs Standard Ergocalciferol for Vitamin D Normalization in Aggressive Non-Hodgkin Lymphoma | not yet recruiting | N/A | 52 | Phramongkutklao College of Medicine and HospitalOTHER | 1 | Jan 26, 2026 | clinicaltrials |
| NCT06693830 | ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL | recruiting | N/A | 40 | Hua-Jay J Cherng, MDOTHER | 1 | Jan 23, 2026 | clinicaltrials |
| NCT05706766 | Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation | recruiting | N/A | 30 | Dana-Farber Cancer InstituteOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07044427 | Fall Risk Assessment and an Exercise Intervention for Prevention of Falls in Multiple Myeloma Patients(Myfall) | recruiting | N/A | 60 | University Hospital HeidelbergOTHER | 1 | Jan 22, 2026 | clinicaltrials |
| NCT07211048 | Anti CD19 Gene Therapy for B-cell Lymphoma | recruiting | N/A | 18 | Anhui Provincial HospitalOTHER_GOV | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07305662 | Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study(KORMED-PA Stud) | not yet recruiting | N/A | 20 | Seoul National University Bundang HospitalOTHER | 1 | Jan 21, 2026 | clinicaltrials |
| NCT07312942 | Effects of Controlled Breathing Added to Therapeutic Exercise in Multiple Myeloma | not yet recruiting | N/A | 32 | Universidad Complutense de MadridOTHER | 0 | Jan 20, 2026 | clinicaltrials |
| NCT07353554 | Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma | not yet recruiting | N/A | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 20, 2026 | clinicaltrials |
| NCT07345741 | Clinical Study on the Safety and Efficacy of CD20/CD19 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin Lymphoma | not yet recruiting | N/A | 28 | Donghua ZhangOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT01599559 | Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma | active not recruiting | N/A | 540 | International Extranodal Lymphoma Study Group (IELSG)OTHER | 14 | Jan 15, 2026 | clinicaltrials |
| NCT06004011 | AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) | recruiting | N/A | 4,100 | ImplenomicsOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT07327138 | Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.(CLAP) | recruiting | N/A | 60 | Bahaa Bou DarghamOTHER | 1 | Jan 8, 2026 | clinicaltrials |
| NCT03794635 | An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer | active not recruiting | N/A | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jan 7, 2026 | clinicaltrials |
| NCT05675982 | Real-Time Monitoring of Circulating Tumor DNA and Study of Prognostic Factors in Patients Treated With CAR-T Cells(RT-CAR) | active not recruiting | N/A | 40 | Centre Henri BecquerelOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT07313878 | Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultrasound Localization Microscopy(HEALED) | recruiting | N/A | 30 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Jan 2, 2026 | clinicaltrials |
| NCT06744075 | Study of the Clearance of Minimal Residual Disease Measured at the End of First-line Treatment in Patients With Lymphoma(CELERITY) | active not recruiting | N/A | 108 | Centre Henri BecquerelOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT07297576 | Safety and Feasibility of Sulforaphane to Promote Early Haematopoietic Recovery After Cord Blood Transplantation | recruiting | N/A | 36 | Institute of Hematology & Blood Diseases Hospital, ChinaOTHER | 1 | Dec 30, 2025 | clinicaltrials |
| NCT05019976 | Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma | active not recruiting | N/A | 30 | University of ChicagoOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT05657652 | CAV Regimen for R/R Ph- B-ALL | recruiting | N/A | 36 | The First Affiliated Hospital of Soochow UniversityOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07100067 | LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma | recruiting | N/A | 35 | Nanjing Legend Biotech Co.INDUSTRY | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07276230 | Quality of Life Assessment of Caregivers of Patients With Multiple Myeloma(ENTRAIDANT) | not yet recruiting | N/A | 27 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Dec 29, 2025 | clinicaltrials |
| NCT07270263 | Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies(HEM-DOAC) | recruiting | N/A | 100 | Medical University of GdanskOTHER | 1 | Dec 26, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Mar 10, 2026source: clinicaltrials